Skip to content

Clinical Validation Study of RTVue Features

Clinical Validation Study of RTVue Features

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01370850
Enrollment
53
Registered
2011-06-10
Start date
2011-03-31
Completion date
2011-04-30
Last updated
2011-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Healthy

Keywords

Retina pathology

Brief summary

To perform a clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology.

Detailed description

Clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology. Subjects to undergo a clinical exam and OCT scanning.

Interventions

None listed

Sponsors

Optovue
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Normal subjects will have normal results from the clinical exam and be free of ocular pathology. * Glaucoma patients will have clinical exam results consistent with glaucoma; they will have visual field defects consistent with glaucoma and/or structural damage consistent with glaucoma. * Retina patients will have clinical exam results consistent with retina pathology.

Exclusion criteria

* Normal subjects will be free of any ocular pathology. * Glaucoma patients will be free of any ocular pathology except glaucoma. * Retina patients will be free of any ocular pathology except any type of retina pathology.

Design outcomes

Primary

MeasureTime frame
Retina measurementat time of study visit (day 1)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026